Human Cancer

Conducts research on diagnostic, risk factors, and treatment at the level of tissue, cellular, molecular and proteomics. Curently, there are three research focuses, namely breast cancer, colorectal cancer, and lymphoid and endocrine malignancies.

On Going Research

  • The Development of Cancer Cell Primary Cultures (from Ovarian, Breast, Lung and Colorectal Cancer Cell).
  • Immunohistochemistry Profile from Lung Cancer.
  • Clinicopathologycal Profile of B Cell Non-
  • Hodgkin Lymphoma (Marginal Zone and Mantle Cell Type) at FKUI/RSCM.
  • The Development of Colorectal Cancer Stem Cell.
  • Colorectal Cancer Stem Cell And Its Immunotherapy.


  • Selvarajan V, Osato M, Nah GSS, Yan J, Chung TH, Voon DCC, Ito Y, Ham MF, Salto- Tellez M, Shimizu N, Choo SN, Fan S, Chng WJ, Ng SB. RUNX3 is Oncogenic in Natural Killer/T- Cell Lymphoma and is Transcriptionally Regulated by MYC. Leukemia 2017:, 1–9.
  • Abdullah M, Syam AF, Meilany S, et al. (2017). The Value of Caspase-3 after the Application of Annona muricata Leaf Extract in COLO-205 Colorectal Cancer Cell Line. Gastroenterology Research and Practice; 4357165. doi:10.1155/2017/4357165.
  • Siah KTH, Gong X, Yang XJ, Whitehead WE, Chen M, Hou X, Pratap N, Ghoshal UC, Syam AF, Abdullah M, Choi MG, Bak YT, Lu CL, Gonlachanvit S, Boon CS, Fang F, Cheong PK, Wu JCY, Gwee KA.(2017). Rome Foundation-Asian Working Team Report: Asian Functional Gastrointestinal Disorder Symptom Clusters. Gut. pii: gutjnl-2016-312852. doi: 10.1136/gutjnl-2016- 312852.
  • Indrawati L, Ascobat P, Bela B, Abdullah M, Surono IS. (2017). The Effect of an Annona Muricata Leaf Extract on Nutritional Status and Cytotoxicity In Colorectal Cancer: A Randomized Controlled Trial. Asia Pac J Clin Nutr; 26(4):606-612. doi: 10.6133/apjcn.062016.02.
  • Abdullah M, Syam AF, Meilany S, Laksono B, Prabu OG, Bekti HS, Indrawati L, Makmun D.(2017). The Value of Caspase-3 after the Application of Annona muricata Leaf Extract in COLO- 205 Colorectal Cancer Cell Line. Gastroenterol Res Pract :4357165. doi: 10.1155/2017/4357165.
  • Xiong L, Gong X, Siah KT, Pratap N, Ghoshal UC, Abdullah M, Syam AF, Bak YT, Choi MG, Lu CL, Gonlachanvit S, Chua AS, Chong KM, Ricaforte-Campos JD, Shi Q, Hou X, Whitehead WE, Gwee KA, Chen M.(2017). Rome Foundation Asian Working Team Report: Real World Treatment Experience of Asian Patients With Functional Bowel Disorders. J Gastroenterol Hepatol. doi: 10.1111/jgh.13730.
  • Murdani A, Kumar A, Chiu HM, Goh KL, Jang BI, Khor CJ, Lau J, Mostafa I, Ramchandani M, Ratanalert S, Tajiri H, Yuen M, Zhang ST, Duforest-Rey D, Rey JF.(2017). WEO Position Statement on Hygiene In Digestive Endoscopy: Focus on Endoscopy Units in Asia and the Middle East. Dig Endosc: 29(1):3-15. doi: 10.1111/den.12745
  • Marleen FS, Syahruddin E, Hudoyo A, Endardjo S. Ekspresi Protein BCL-2 pada Sediaan Blok Parafin Jaringan Kanker Paru. Jurnal Respirology Indonesia: 29(4):210-8.
  • Wuryanti S, Andrijono, Susworo, Witjaksono. (2015). The Effect of High Poly Unsaturated Fatty Acid (PUFA) Dietary Supplementation on Inflammatory Status of Patients with Advanced Cervical Cancer on Radiation Treatment. Acta Medica Indonesiana: 47(1): 45-9.
  • Abdullah M, Sudoyo AW, Utomo AR, Fauzi A, Rani AA. (2012). Molecular Profile of Colorectal Cancer in Indonesia: Is There Another Pathway?. Gastroenterology and Hepatology From Bed to Bench: 5(2):71-78.
  • Reksodiputro AH, Irawan C, Hardjolukito E, Suzanna E, Rinaldi I, Mulansari NA, Ham MF. (2011). Non-Hodgkin’s Lymphoma in Jakarta. Indonesia J Cancer 5: 129-33.
  • Andrijono, Muhilal M. (2010). Prevention of Post-Mole Malignant Trophoblastic Disease with Vitamin A. Pacific Journal of Cancer Prevention (APJCP): 11(2):567-70.
  • Syahruddin, E. (2010). Respons dan Toleransi Pasien Adenokarsinoma Paru Stage III dan IV Untuk Pemberian Kemoterapi. Jurnal Respirology Indonesia; 30(2): 105-111.


  • Samsung Medical Center.
  • LITBANG Ministry of Health.
  • Leiden University of Medical Centre and Tsukuba
  • University via FKUI.
  • Female Cancer Program.